» Articles » PMID: 35328770

Structural Plasticity of the Hippocampus in Neurodegenerative Diseases

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Mar 25
PMID 35328770
Authors
Affiliations
Soon will be listed here.
Abstract

Neuroplasticity is the capacity of neural networks in the brain to alter through development and rearrangement. It can be classified as structural and functional plasticity. The hippocampus is more susceptible to neuroplasticity as compared to other brain regions. Structural modifications in the hippocampus underpin several neurodegenerative diseases that exhibit cognitive and emotional dysregulation. This article reviews the findings of several preclinical and clinical studies about the role of structural plasticity in the hippocampus in neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, Huntington's disease, and multiple sclerosis. In this study, literature was surveyed using Google Scholar, PubMed, Web of Science, and Scopus, to review the mechanisms that underlie the alterations in the structural plasticity of the hippocampus in neurodegenerative diseases. This review summarizes the role of structural plasticity in the hippocampus for the etiopathogenesis of neurodegenerative diseases and identifies the current focus and gaps in knowledge about hippocampal dysfunctions. Ultimately, this information will be useful to propel future mechanistic and therapeutic research in neurodegenerative diseases.

Citing Articles

Differential Glial Response and Neurodegenerative Patterns in CA1, CA3, and DG Hippocampal Regions of 5XFAD Mice.

Nairuz T, Heo J, Lee J Int J Mol Sci. 2024; 25(22).

PMID: 39596222 PMC: 11594373. DOI: 10.3390/ijms252212156.


Genomic factors associated with substance use disorder relapse: A critical review.

Al-Marzooqi N, Al-Suhail H, AlRefai M, Alhaj H Addict Behav Rep. 2024; 20:100569.

PMID: 39553284 PMC: 11568783. DOI: 10.1016/j.abrep.2024.100569.


Widespread Gene Editing in the Brain via In Utero Delivery of mRNA Using Acid-Degradable Lipid Nanoparticles.

Gao K, Han H, Cranick M, Zhao S, Xu S, Yin B ACS Nano. 2024; 18(44):30293-30306.

PMID: 39445691 PMC: 11544762. DOI: 10.1021/acsnano.4c05169.


Spatial regulation of NMN supplementation on brain lipid metabolism upon subacute and sub-chronic PM exposure in C57BL/6 mice.

Jiang Y, Li F, Ye L, Zhang R, Chen S, Peng H Part Fibre Toxicol. 2024; 21(1):35.

PMID: 39252011 PMC: 11385136. DOI: 10.1186/s12989-024-00597-3.


LSD Modulates Proteins Involved in Cell Proteostasis, Energy Metabolism and Neuroplasticity in Human Cerebral Organoids.

N Costa M, Goto-Silva L, M Nascimento J, Domith I, Karmirian K, Feilding A ACS Omega. 2024; 9(34):36553-36568.

PMID: 39220485 PMC: 11360045. DOI: 10.1021/acsomega.4c04712.


References
1.
Cattaneo E, Zuccato C, Tartari M . Normal huntingtin function: an alternative approach to Huntington's disease. Nat Rev Neurosci. 2005; 6(12):919-30. DOI: 10.1038/nrn1806. View

2.
Steele J, Brautigam H, Short J, Sowa A, Shi M, Yadav A . Early fear memory defects are associated with altered synaptic plasticity and molecular architecture in the TgCRND8 Alzheimer's disease mouse model. J Comp Neurol. 2014; 522(10):2319-35. PMC: 4251468. DOI: 10.1002/cne.23536. View

3.
Michailidou I, Willems J, Kooi E, van Eden C, Gold S, Geurts J . Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus. Ann Neurol. 2015; 77(6):1007-26. DOI: 10.1002/ana.24398. View

4.
Beeldman E, Raaphorst J, Klein Twennaar M, de Visser M, Schmand B, de Haan R . The cognitive profile of ALS: a systematic review and meta-analysis update. J Neurol Neurosurg Psychiatry. 2015; 87(6):611-9. DOI: 10.1136/jnnp-2015-310734. View

5.
Guo S, Xu J, Wei N, Han J, Xue R, Xu P . Honokiol Attenuates the Memory Impairments, Oxidative Stress, Neuroinflammation, and GSK-3β Activation in Vascular Dementia Rats. J Alzheimers Dis. 2019; 71(1):97-108. DOI: 10.3233/JAD-190324. View